高鴻股份(000851.SZ):擬18萬元價格轉讓下屬子公司高鴻科技100%股權
格隆匯12月29日丨高鴻股份(000851.SZ)公佈,公司擬向北京鑫恆眾達科技有限公司(以下簡稱:“鑫恆眾達”)和自然人鄧博轉讓下屬子公司北京大唐高鴻科技發展有限公司(簡稱“高鴻科技”)100%股權,本次交易價格為18萬元。轉讓完成後公司不再持有高鴻科技的股權,高鴻科技不再納入公司合併報表範圍內。
公司IT銷售相關業務進行內部整合,精簡機構,特對外轉讓高鴻科技股權,本次轉讓符合公司戰略發展需要。經公司財務部門初步測算,本次股權出售事項若順利實施,預計將增加公司2021年度合併報表淨利潤約535.29萬元人民幣(未經審計),佔2020年度經審計合併報表歸屬於上市公司股東淨利潤的4.40%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.